Sanofi has reported that the high-dose formulation of its influenza vaccine, Elfueda (known as Fluzone High-Dose in the US), ...

The study demonstrated strong clinical accuracy in differentiating pancreatic cancer patients from control subjects ...

Inizio is leading the way in Intelligent Commercialization™ by uniting proprietary AI-powered platforms, deep scientific ...

Mission Therapeutics, a clinical-stage biotechnology company, has raised $13.3m to advance the clinical development of its ...

International Patient Engagement Day 2025 has been launched by the International Society for Patient Engagement Professionals ...

Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotech, is advancing PP405, its lead candidate for the ...

London’s King’s Cross tunnel has been illuminated in pink for the first time ever, marking Breast Cancer Awareness Month ...

Merck has appointed David Weinreich as global head of R&D and chief medical officer of its healthcare business sector. Based ...

Eli Lilly has appointed Peter Marks, former director of the US Food and Drug Administration’s (FDA) Centre for Biologics ...

AI in pharmaceuticals spans blue-sky possibilities to immediate practical applications delivering value today. AI-powered ...

The second phase of Precision Oncology Ireland (POI), the country’s largest cancer research programme has been launched by ...

Bristol Myers Squibb (BMS) has agreed to acquire Orbital Therapeutics in a deal valued at $1.5bn. Robert Plenge, executive VP ...